Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer

Infection and Immunity

Volumn 77, Issue 5, 2009, Pages 2221-2229

  Trollet, C ^a,b,c,d   Pereira, Y ^e   Burgain, A ^a,b,c,d   Litzler, E ^a,b,c,d   Mezrahi, M ^a,b,c,d   Seguin, J ^a,b,c,d   Manich, M ^e   Popoff, M R ^e   Scherman, D ^a,b,c,d   Bigey, P ^a,b,c,d  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM ANTISERUM; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; NEUTRALIZING ANTIBODY; PLASMID DNA; ANTITOXIN; BACTERIUM ANTIBODY; BOTULINUM TOXIN; DNA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELLULAR DISTRIBUTION; CODON; CONTROLLED STUDY; DRUG SYNTHESIS; ELECTROPORATION; FEMALE; MELANOMA B16; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ANIMAL; BLOOD; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METHODOLOGY; PLASMID;

ANIMALS; ANTIBODIES, BACTERIAL; ANTITOXINS; BOTULINUM TOXINS; ELECTROPORATION; FEMALE; MICE; PLASMIDS; VACCINES, DNA;

EID: 65449142925     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01269-08     Document Type: Article

References (51)

1. Arnon, S. S., R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, J. Hauer, M. Layton, S. Lillibridge, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, D. L. Swerdlow, and K. Tonat. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070.
2. Ashok, M. S., and P. N. Rangarajan. 2002. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model. Vaccine 20:1563-1570.
3. Bachy, M., F. Boudet, M. Bureau, Y. Girerd-Chambaz, P. Wils, D. Scherman, and C. Meric. 2001. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine 19:1688-1693.
4. Bennett, A. M., S. D. Perkins, and J. L. Holley. 2003. DNA vaccination protects against Botulinum neurotoxin type F. Vaccine 21:3110-3117.
5. Bettan, M., F. Emmanuel, R. Darteil, J. M. Caillaud, F. Soubrier, P. Delaere, D. Branelec, A. Mahfoudi, N. Duverger, and D. Scherman. 2000. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol. Ther. 2:204-210.
6. Bollerot, K., D. Sugiyama, V. Escriou, R. Gautier, S. Tozer, D. Scherman, and T. Jaffredo. 2006. Widespread lipoplex-mediated gene transfer to vascular endothelial cells and hemangioblasts in the vertebrate embryo. Dev. Dyn. 235:105-114. (Pubitemid 46939707)
7. Boyle, J. S., C. Koniaras, and A. M. Lew. 1997. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9:1897-1906.
8. Chertow, D. S., E. T. Tan, S. E. Maslanka, J. Schulte, E. A. Bresnitz, R. S. Weisman, J. Bernstein, S. M. Marcus, S. Kumar, J. Malecki, J. Sobel, and C. R. Braden. 2006. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 296:2476-2479.
9. Clayton, J., and J. L. Middlebrook. 2000. Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A. Vaccine 18:1855-1862.
10. Doria-Rose, N. A., and N. L. Haigwood. 2003. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31:207-216.
11. Frelin, L., G. Ahlen, M. Alheim, O. Weiland, C. Barnfield, P. Liljestrom, and M. Sallberg. 2004. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther. 11:522-533. (Pubitemid 38443519)
12. Geissler, M., V. Bruss, S. Michalak, B. Hockenjos, D. Ortmann, W. B. Offensperger, J. R. Wands, and H. E. Blum. 1999. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations. J. Virol. 73:4284-4292. (Pubitemid 29189875)
13. Goldspink, G. 2003. Skeletal muscle as an artificial endocrine tissue. Best Pract. Res. Clin. Endocrinol. Metab. 17:211-222. (Pubitemid 36740782)
14. Gronevik, E., I. Mathiesen, and T. Lomo. 2005. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J. Gene Med. 7:1246-1254. (Pubitemid 41335176)
15. Gronevik, E., S. Tollefsen, L. I. Sikkeland, T. Haug, T. E. Tjelle, and I. Mathiesen. 2003. DNA transfection of mononuclear cells in muscle tissue. J. Gene Med. 5:909-917. (Pubitemid 40310416)
16. Harrison, R. A. 2004. Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming. Vaccine 22:1648-1655.
17. Harrison, R. A., and A. E. Bianco. 2000. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis. Parasite Immunol. 22:249-257.
18. Jathoul, A. P., J. L. Holley, and H. S. Garmory. 2004. Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters. Vaccine 22:3942-3946.
19. Kutzler, M. A., and D. B. Weiner. 2008. DNA vaccines: ready for prime time? Nat. Rev. Genet. 9:776-788.
20. LaPenotiere, H. F., M. A. Clayton, and J. L. Middlebrook. 1995. Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen. Toxicon 33:1383-1386.
21. Law, M., R. M. Cardoso, I. A. Wilson, and D. R. Burton. 2007. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. J. Virol. 81:4272-4285. (Pubitemid 46586921)
22. Leblond, J., N. Mignet, C. Largeau, M. V. Spanedda, J. Seguin, D. Scherman, and J. Herscovici. 2007. Lipopolythioureas: a new non-cationic system for gene transfer. Bioconjug. Chem. 18:484-493.
23. Li, Z., H. Zhang, X. Fan, Y. Zhang, J. Huang, Q. Liu, T. E. Tjelle, I. Mathiesen, R. Kjeken, and S. Xiong. 2006. DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine 24:4565-4568.
24. Lindstrom, M., M. Nevas, J. Kurki, R. Sauna-aho, A. Latvala-Kiesila, I. Polonen, and H. Korkeala. 2004. Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland. J. Clin. Microbiol. 42:4718-4725. (Pubitemid 39362394)
25. Lu, Q. L., G. Bou-Gharios, and T. A. Partridge. 2003. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10:131-142.
26. Mahajan, S. T., and L. Brubaker. 2007. Botulinum toxin: from life-threatening disease to novel medical therapy. Am. J. Obstet. Gynecol. 196:7-15.
27. Mahrhold, S., A. Rummel, H. Bigalke, B. Davletov, and T. Binz. 2006. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 580:2011-2014.
28. Martel-Renoir, D., V. Trochon-Joseph, A. Galaup, C. Bouquet, F. Griscelli, P. Opolon, D. Opolon, E. Connault, L. Mir, and M. Perricaudet. 2003. Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect. Mol. Ther. 8:425-433.
29. Mayers, C. N., J. L. Holley, and T. Brooks. 2001. Antitoxin therapy for botulinum intoxication. Rev. Med. Microbiol. 12:29-37. (Pubitemid 32095753)
30. McClements, W. L., M. E. Armstrong, R. D. Keys, and M. A. Liu. 1997. The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs. Vaccine 15:857-860.
31. Middlebrook, J. L. 2005. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Adv. Drug Deliv. Rev. 57:1415-1423. (Pubitemid 40791119)
32. Miller, M., G. Rekas, K. Dayball, Y. H. Wan, and J. Bramson. 2004. The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo. Vaccine 22:2517-2523.
33. Mir, L. M., M. F. Bureau, J. Gehl, R. Rangara, D. Rouy, J. M. Caillaud, P. Delaere, D. Branellec, B. Schwartz, and D. Scherman. 1999. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96:4262-4267.
34. Narum, D. L., S. Kumar, W. O. Rogers, S. R. Fuhrmann, H. Liang, M. Oakley, A. Taye, B. K. Sim, and S. L. Hoffman. 2001. Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect. Immun. 69:7250-7253.
35. Otten, G., M. Schaefer, B. Doe, H. Liu, I. Srivastava, J. zur Megede, D. O'Hagan, J. Donnelly, G. Widera, D. Rabussay, M. G. Lewis, S. Barnett, and J. B. Ulmer. 2004. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22:2489-2493.
36. Pellizzari, R., O. Rossetto, G. Schiavo, and C. Montecucco. 1999. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos. Trans. R. Soc. Lond. B 354:259-268.
37. Peng, B., Y. Zhao, L. Xu, and Y. Xu. 2007. Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine 25:2064-2073.
38. Rainey, G. J., and J. A. Young. 2004. Antitoxins: novel strategies to target agents of bioterrorism. Nat. Rev. Microbiol. 2:721-726.
39. Rummel, A., T. Eichner, T. Weil, T. Karnath, A. Gutcaits, S. Mahrhold, K. Sandhoff, R. L. Proia, K. R. Acharya, H. Bigalke, and T. Binz. 2007. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. USA 104:359-364.
40. Scheerlinck, J. P., J. Karlis, T. E. Tjelle, P. J. Presidente, I. Mathiesen, and S. E. Newton. 2004. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22:1820-1825.
41. Sedegah, M., Y. Charoenvit, L. Minh, M. Belmonte, V. F. Majam, S. Abot, H. Ganeshan, S. Kumar, D. J. Bacon, A. Stowers, D. L. Narum, D. J. Carucci, and W. O. Rogers. 2004. Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther. 11:448-456. (Pubitemid 38313165)
42. Shone, C. C., and H. S. Tranter. 1995. Growth of clostridia and preparation of their neurotoxins. Curr. Top. Microbiol. Immunol. 195:143-160.
43. Shyu, R. H., M. F. Shaio, S. S. Tang, H. F. Shyu, C. F. Lee, M. H. Tsai, J. E. Smith, H. H. Huang, J. J. Wey, J. L. Huang, and H. H. Chang. 2000. DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice. J. Biomed. Sci. 7:51-57. (Pubitemid 30046571)
44. Srivastava, I. K., and M. A. Liu. 2003. Gene vaccines. Ann. Intern. Med. 138:550-559.
45. Stratford, R., G. Douce, L. Zhang-Barber, N. Fairweather, J. Eskola, and G. Dougan. 2000. Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine 19:810-815.
46. Tang, D. C., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154.
47. Tavallaie, M., A. Chenal, D. Gillet, Y. Pereira, M. Manich, M. Gibert, S. Raffestin, M. R. Popoff, and J. C. Marvaud. 2004. Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett. 572:299-306. (Pubitemid 39092553)
48. Trollet, C., C. Bloquel, D. Scherman, and P. Bigey. 2006. Electrotransfer into skeletal muscle for protein expression. Curr. Gene Ther. 6:561-578. (Pubitemid 44524460)
49. Trollet, C., M. Ibanez-Ruiz, C. Bloquel, G. Valin, D. Scherman, and P. Bigey. 2004. Regulation of gene expression using a conditional RNA antisense strategy. J. Genome Sci. Technol. 3:1-13.
50. Turton, K., J. A. Chaddock, and K. R. Acharya. 2002. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27:552-558.
51. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.